FARALLON CAPITAL MANAGEMENT LLC Q3 2019 Filing
Filed November 14, 2019
Portfolio Value
$9.8T
Holdings
89
Report Date
Q3 2019
Filing Type
13F-HR
All Holdings (89 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | SPYSPDR S&P 500 ETF TR | 3,306,000 | $981.1B | 10.05% | Put |
| 2 | AABAUSDALTABA INC | 34,189,499 | $666.0B | 6.82% | |
| 3 | WABWABTEC CORP | 6,270,986 | $450.6B | 4.62% | |
| 4 | FISFIDELITY NATL INFORMATION SV | 3,055,609 | $405.7B | 4.16% | |
| 5 | IQVIQVIA HLDGS INC | 2,640,179 | $394.4B | 4.04% | |
| 6 | BABAALIBABA GROUP HLDG LTD | 2,174,715 | $363.7B | 3.73% | |
| 7 | IACIEURIAC INTERACTIVECORP | 1,457,500 | $317.7B | 3.26% | |
| 8 | GOOGALPHABET INC | 250,037 | $304.8B | 3.12% | |
| 9 | CHTRCHARTER COMMUNICATIONS INC N | 705,309 | $290.7B | 2.98% | |
| 10 | ELVANTHEM INC | 1,062,883 | $255.2B | 2.61% | |
| 11 | SHWSHERWIN WILLIAMS CO | 449,952 | $247.4B | 2.54% | |
| 12 | METAFACEBOOK INC | 1,363,514 | $242.8B | 2.49% | |
| 13 | PLYAPLAYA HOTELS & RESORTS NV | 30,606,930 | $239.7B | 2.46% | |
| 14 | —IHS MARKIT LTD | 3,575,384 | $239.1B | 2.45% | |
| 15 | VVISA INC | 1,295,257 | $222.8B | 2.28% | |
| 16 | EQIXEQUINIX INC | 371,670 | $214.4B | 2.20% | |
| 17 | SPGIS&P GLOBAL INC | 832,314 | $203.9B | 2.09% | |
| 18 | MSFTMICROSOFT CORP | 1,414,272 | $196.6B | 2.01% | |
| 19 | CTXSEURCITRIX SYS INC | 1,900,323 | $183.4B | 1.88% | |
| 20 | GDGENERAL DYNAMICS CORP | 991,732 | $181.2B | 1.86% | |
| 21 | ZAYOEURZAYO GROUP HLDGS INC | 4,944,247 | $167.6B | 1.72% | |
| 22 | CICIGNA CORP NEW | 1,062,790 | $161.3B | 1.65% | |
| 23 | —BUCKEYE PARTNERS L P | 3,900,000 | $160.3B | 1.64% | |
| 24 | ASNDASCENDIS PHARMA A S | 1,550,000 | $149.3B | 1.53% | |
| 25 | PANWPALO ALTO NETWORKS INC | 610,000 | $124.3B | 1.27% | |
| 26 | ALNYALNYLAM PHARMACEUTICALS INC | 1,500,000 | $120.6B | 1.24% | |
| 27 | IOVAIOVANCE BIOTHERAPEUTICS INC | 6,025,000 | $109.7B | 1.12% | |
| 28 | AZNASTRAZENECA PLC | 2,375,785 | $105.9B | 1.08% | |
| 29 | —MYOKARDIA INC | 2,030,397 | $105.9B | 1.08% | |
| 30 | SESEA LTD | 3,375,000 | $104.5B | 1.07% | |
| 31 | TRUTRANSUNION | 1,255,138 | $101.8B | 1.04% | |
| 32 | XLRNACCELERON PHARMA INC | 2,400,000 | $94.8B | 0.97% | |
| 33 | EFXEQUIFAX INC | 635,056 | $89.3B | 0.92% | |
| 34 | —ALDER BIOPHARMACEUTICALS INC | 4,165,000 | $78.6B | 0.80% | |
| 35 | GBTUSDGLOBAL BLOOD THERAPEUTICS IN | 1,612,069 | $78.2B | 0.80% | |
| 36 | —TRINITY MERGER CORP | 75,000,000 | $77.3B | 0.79% | |
| 37 | ENTAENANTA PHARMACEUTICALS INC | 1,274,212 | $76.6B | 0.78% | |
| 38 | ABBVABBVIE INC | 1,000,000 | $75.7B | 0.78% | |
| 39 | —ZOGENIX INC | 1,750,000 | $70.1B | 0.72% | |
| 40 | GRFSGRIFOLS S A | 3,113,222 | $62.4B | 0.64% | |
| 41 | BKNGBOOKING HLDGS INC | 31,139 | $61.1B | 0.63% | |
| 42 | CVSCVS HEALTH CORP | 900,000 | $56.8B | 0.58% | |
| 43 | —RADIUS HEALTH INC | 2,054,486 | $52.9B | 0.54% | |
| 44 | SG7SAGE THERAPEUTICS INC | 372,800 | $52.3B | 0.54% | |
| 45 | —ZYMEWORKS INC | 1,731,500 | $42.9B | 0.44% | |
| 46 | CARAEURCARA THERAPEUTICS INC | 2,150,000 | $39.3B | 0.40% | |
| 47 | —PROGENICS PHARMACEUTICALS IN | 7,350,000 | $37.2B | 0.38% | |
| 48 | FGENEURFIBROGEN INC | 1,000,000 | $37.0B | 0.38% | |
| 49 | NXPINXP SEMICONDUCTORS N V | 325,000 | $35.5B | 0.36% | |
| 50 | RCREADY CAP CORP | 2,205,132 | $35.1B | 0.36% | |
| 51 | FATEFATE THERAPEUTICS INC | 2,250,000 | $34.9B | 0.36% | |
| 52 | UBERUBER TECHNOLOGIES INC | 1,102,500 | $33.6B | 0.34% | Put |
| 53 | EX9EXELIXIS INC | 1,750,000 | $30.9B | 0.32% | |
| 54 | AMRNAMARIN CORP PLC | 2,000,600 | $30.3B | 0.31% | |
| 55 | —ZEALAND PHARMA A S | 1,010,000 | $25.6B | 0.26% | |
| 56 | DCPHEURDECIPHERA PHARMACEUTICALS IN | 750,000 | $25.5B | 0.26% | |
| 57 | —PTC THERAPEUTICS INC | 24,176,000 | $25.2B | 0.26% | |
| 58 | NVTA1EURINVITAE CORP | 1,300,000 | $25.1B | 0.26% | |
| 59 | PTCTPTC THERAPEUTICS INC | 726,986 | $24.6B | 0.25% | |
| 60 | SYMCEURSYMANTEC CORP | 1,030,000 | $24.3B | 0.25% | |
| 61 | VCYTVERACYTE INC | 1,000,000 | $24.0B | 0.25% | |
| 62 | —STEMLINE THERAPEUTICS INC | 2,300,000 | $23.9B | 0.25% | |
| 63 | MRTXEURMIRATI THERAPEUTICS INC | 300,000 | $23.4B | 0.24% | |
| 64 | CRSPCRISPR THERAPEUTICS AG | 560,367 | $23.0B | 0.24% | |
| 65 | —AVROBIO INC | 1,550,000 | $21.9B | 0.22% | |
| 66 | ARWRARROWHEAD PHARMACEUTICALS IN | 650,000 | $18.3B | 0.19% | |
| 67 | PTGXPROTAGONIST THERAPEUTICS INC | 1,500,000 | $18.0B | 0.18% | |
| 68 | —SOLARCITY CORP | 17,370,000 | $17.2B | 0.18% | |
| 69 | 1T7TRICIDA INC | 500,000 | $15.4B | 0.16% | |
| 70 | RETAEURREATA PHARMACEUTICALS INC | 182,060 | $14.6B | 0.15% | |
| 71 | CCXIEURCHEMOCENTRYX INC | 2,013,396 | $13.7B | 0.14% | |
| 72 | —QUOTIENT LTD | 1,700,000 | $13.2B | 0.14% | |
| 73 | ACADACADIA PHARMACEUTICALS INC | 350,000 | $12.6B | 0.13% | |
| 74 | CLDNEUREIGER BIOPHARMACEUTICALS INC | 1,125,000 | $11.5B | 0.12% | |
| 75 | YB4PSAVARA INC | 3,510,787 | $9.3B | 0.10% | |
| 76 | CLVS 1.25 05/01/25CLOVIS ONCOLOGY INC | 18,801,000 | $8.3B | 0.08% | |
| 77 | AXSMAXSOME THERAPEUTICS INC | 400,000 | $8.1B | 0.08% | |
| 78 | XGNEXAGEN INC | 363,336 | $5.6B | 0.06% | |
| 79 | —PFENEX INC | 600,000 | $5.1B | 0.05% | |
| 80 | —CYCLERION THERAPEUTICS INC | 376,628 | $4.6B | 0.05% | |
| 81 | QUREUNIQURE NV | 100,922 | $4.0B | 0.04% | |
| 82 | SNYSANOFI | 6,827,805 | $3.9B | 0.04% | |
| 83 | DMTKQDERMTECH INC | 615,385 | $3.4B | 0.04% | |
| 84 | —PHASEBIO PHARMACEUTICALS INC | 807,928 | $3.4B | 0.03% | |
| 85 | —APTINYX INC | 674,141 | $2.4B | 0.02% | |
| 86 | GOSSGOSSAMER BIO INC | 100,712 | $1.7B | 0.02% | |
| 87 | COHRII VI INC | 47,687 | $1.7B | 0.02% | |
| 88 | —ZAFGEN INC | 1,808,360 | $1.3B | 0.01% | |
| 89 | —RADIUS HEALTH INC | 1,250,000 | $1.1B | 0.01% |